NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 6.20% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.75% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 5.57% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.40% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 5.25% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 5.09% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 4.90% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 4.89% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.79% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.58% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 4.06% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.97% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.73% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 3.69% |
| DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.58% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 3.32% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 3.23% |
| AVXL | Anavex Life Sciences Corp | Healthcare | Biotechnology | 3.21% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 3.17% |